STOCKHOLDER ALERT: Abbott Cooper PLLC Announces Investigation Into Possible Violations of Fiduciary Duty by the Board of Mei Pharma, Inc.

STAMFORD, CT / ACCESSWIRE / September 18, 2023 / Abbott Cooper PLLC is investigating MEI Pharma, Inc. (Nasdaq:MEI) ("MEI" or the "Company") on behalf of the Company's investors.

The investigation seeks to determine the extent to which MEI's stockholders have been injured as a result of any efforts by MEI's board of directors to entrench themselves and avoid being held accountable by MEI's true owners.

MEI stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing or visiting our website at for additional information about this investigation as well as their legal rights and options.

Abbott Cooper PLLC is dedicated to shareholders' rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit


Abbott Cooper PLLC
J. Abbott R. Cooper, Esq.
(475) 333-0674

Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Abbott Cooper PLLC

View source version on

NOTE: This content is not written by or endorsed by "WPRI", its advertisers, or Nexstar Media Inc.

For inquiries or corrections to Press Releases, please reach out to Accesswire.